REPLIGEN CORP cotiza a 171.29 USD y tiene una capitalización bursátil de $10.9B. En los últimos 12 meses ha facturado $785M con un margen de flujo de caja libre del 12.7%. Cotiza a 97.1 veces su flujo de caja libre (P/FCF) y a un PER de 261.8. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart…
| Métrica | RGEN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 52.3% | 57.0% | -4.7% |
| Operating Margin | 7.5% | -38.6% | +46.1% |
| Net Margin | 6.6% | -33.6% | +40.2% |
| FCF Margin | 12.7% | -13.9% | +26.6% |
| ROE | 2.3% | -40.4% | +42.7% |
| ROA | 1.7% | -32.0% | +33.7% |
| Current Ratio | 8.37 | 2.84 | +5.53 |
| Debt / Equity | 0.26 | 0.28 | -0.02 |